Literature DB >> 28660958

Privileged chiral N-heterocyclic carbene ligands for asymmetric transition-metal catalysis.

Daniel Janssen-Müller1, Christoph Schlepphorst, Frank Glorius.   

Abstract

Chiral ligands play a central role in enantioselective transition-metal catalysis. The success of achiral N-heterocyclic carbenes (NHCs) as stable electron-rich neutral ligands in homogeneous catalysis led to the development of a manifold of chiral NHCs as stereodirecting ancillary ligands for various enantioselective transformations. Due to the modular design of NHCs and the ease of access to their azolium salt precursors, tailor-made NHCs are readily available. Many chiral NHC scaffolds have been synthesised and tested in catalysis. Herein, we highlight only those NHC structures which have enabled high degrees of enantioselectivity in transition-metal catalysis. Following a brief introduction to the field of chiral NHCs, this tutorial review introduces different categories of chiral NHCs and provides a guide to the structural fine-tuning of ligand requirements and stereochemical models.

Entities:  

Year:  2017        PMID: 28660958     DOI: 10.1039/c7cs00200a

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN: 0306-0012            Impact factor:   54.564


  18 in total

1.  Structure and Reactivity of Highly Twisted N-Acylimidazoles.

Authors:  Elizabeth A Stone; Brandon Q Mercado; Scott J Miller
Journal:  Org Lett       Date:  2019-03-12       Impact factor: 6.005

2.  Catalytic, Enantioselective syn-Diamination of Alkenes.

Authors:  Zhonglin Tao; Bradley B Gilbert; Scott E Denmark
Journal:  J Am Chem Soc       Date:  2019-11-19       Impact factor: 15.419

3.  A Chiral Macrocyclic Tetra-N-Heterocyclic Carbene Yields an "All Carbene" Iron Alkylidene Complex.

Authors:  Joseph F DeJesus; David M Jenkins
Journal:  Chemistry       Date:  2020-01-22       Impact factor: 5.236

4.  Parameterization of Acyclic Diaminocarbene Ligands Applied to a Gold(I)-Catalyzed Enantioselective Tandem Rearrangement/Cyclization.

Authors:  Zachary L Niemeyer; Suresh Pindi; Dimitri A Khrakovsky; Christian N Kuzniewski; Cynthia M Hong; Leo A Joyce; Matthew S Sigman; F Dean Toste
Journal:  J Am Chem Soc       Date:  2017-09-08       Impact factor: 15.419

5.  Fine-tuning the efficiency of para-hydrogen-induced hyperpolarization by rational N-heterocyclic carbene design.

Authors:  Peter J Rayner; Philip Norcott; Kate M Appleby; Wissam Iali; Richard O John; Sam J Hart; Adrian C Whitwood; Simon B Duckett
Journal:  Nat Commun       Date:  2018-10-12       Impact factor: 14.919

6.  2-Unsubstituted Imidazole N-Oxides as Novel Precursors of Chiral 3-Alkoxyimidazol-2-ylidenes Derived from trans-1,2-Diaminocyclohexane and Other Chiral Amino Compounds.

Authors:  Grzegorz Mlostoń; Małgorzata Celeda; Marcin Jasiński; Katarzyna Urbaniak; Przemysław J Boratyński; Peter R Schreiner; Heinz Heimgartner
Journal:  Molecules       Date:  2019-12-02       Impact factor: 4.411

7.  B-B Cleavage and Ring-Expansion of a 1,4,2,3-Diazadiborinine with N-Heterocyclic Carbenes.

Authors:  Torsten Thiess; Soren K Mellerup; Holger Braunschweig
Journal:  Chemistry       Date:  2019-09-19       Impact factor: 5.236

8.  Synergic Deprotonation Generates Alkali-Metal Salts of Tethered Fluorenide-NHC Ligands Co-Complexed to Alkali-Metal Amides.

Authors:  Kieren J Evans; Stephen M Mansell
Journal:  Chemistry       Date:  2019-02-19       Impact factor: 5.236

9.  The debut of chiral cyclic (alkyl)(amino)carbenes (CAACs) in enantioselective catalysis.

Authors:  Delphine Pichon; Michele Soleilhavoup; Jennifer Morvan; Glen P Junor; Thomas Vives; Christophe Crévisy; Vincent Lavallo; Jean-Marc Campagne; Marc Mauduit; Rodolphe Jazzar; Guy Bertrand
Journal:  Chem Sci       Date:  2019-07-06       Impact factor: 9.825

10.  Copper-catalyzed enantioselective conjugate reduction of α,β-unsaturated esters with chiral phenol-carbene ligands.

Authors:  Shohei Mimura; Sho Mizushima; Yohei Shimizu; Masaya Sawamura
Journal:  Beilstein J Org Chem       Date:  2020-03-31       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.